A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses
- Status
- COMPLETED
- Phase
- PHASE1
A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE4
Testing the AVI-7100 Flu Drug in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza
- Status
- COMPLETED
- Phase
- PHASE2
The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old
- Status
- COMPLETED
- Phase
- PHASE4
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections
- Status
- COMPLETED
- Phase
- PHASE4
Use of Probiotics to Prevent Influenza
- Status
- COMPLETED
- Phase
- NA
High Dose Influenza Vaccine in Nursing Home - Pilot Study
- Status
- COMPLETED
- Phase
- PHASE4
Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza
- Status
- UNKNOWN
- Phase
- PHASE2
Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection
- Status
- COMPLETED
- Phase
- PHASE1
Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK
- Status
- COMPLETED
- Phase
- N/A
Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age
- Status
- COMPLETED
- Phase
- PHASE3
Routes of Immunization and Flu Immune Responses
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2